SCHEMBL2592634

SCHEMBL2592634

c1ccc2c(c1)Nc1cccnc1S2

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 3/20 0.66
ALDH1A1 P00352 2/20 0.66
MAPK10 P53779 1/20 0.66
HSD17B10 Q99714 1/20 0.66
MAPT P10636 8/20 0.66
GAA P10253 7/20 0.66
SMN1; SMN2 Q16637 2/20 0.66
KDM4E B2RXH2 1/20 0.66
HPGD P15428 1/20 0.66
NOX1 Q9Y5S8 10/20 0.59
MEN1 O00255 3/20 0.59
KMT2A Q03164 3/20 0.59
SNCA P37840 3/20 0.59
BCHE P06276 2/20 0.59
ACHE P22303 2/20 0.59
TDP1 Q9NUW8 2/20 0.59
CYP1A2 P05177 1/20 0.59
POLB P06746 1/20 0.59
CYP3A4 P08684 1/20 0.59
ADORA3 P0DMS8 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9100460 0.80 ALDH1A1 (0.78) ALOX15ALDH1A1MAPK10HSD17B10MAPT
SCHEMBL9178250 0.80 ALDH1A1 (1.00) ALOX15ALDH1A1MAPK10HSD17B10MAPT
SCHEMBL2575044 0.79 MAPT (1.00) ALOX15ALDH1A1MAPK10HSD17B10MAPT
SCHEMBL30401814 0.77 MAPT (0.66) ALOX15ALDH1A1MAPK10HSD17B10MAPT
SCHEMBL459986 0.77 MAPT (0.66) ALOX15ALDH1A1MAPK10HSD17B10MAPT
Phenothiazine SCHEMBL5338471 0.77 NOX1 (0.59) ALOX15ALDH1A1MAPK10HSD17B10MAPT
Phenothiazine SCHEMBL9114 0.76 NOX1 (1.00) ALOX15ALDH1A1HSD17B10MAPTGAA
Phenothiazine SCHEMBL2504207 0.76 NOX1 (1.00) ALOX15ALDH1A1HSD17B10MAPTGAA
Phenothiazine SCHEMBL6315328 0.76 NOX1 (1.00) ALOX15ALDH1A1HSD17B10MAPTGAA
Phenothiazine SCHEMBL29349533 0.76 NOX1 (1.00) ALOX15ALDH1A1HSD17B10MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180265800-A1 Lubricant Composition BASF CORPORATION 2018-09-20 US disclosed
EP-3344735-A1 LUBRICANT COMPOSITION BASF SE (DE) 2018-07-11 EP disclosed
WO-2017040965-A1 LUBRICANT COMPOSITION BASF SE (DE) 2017-03-09 WO disclosed
WO-2017040965-A1 LUBRICANT COMPOSITION BASF SE (DE) 2017-03-09 WO disclosed
EP-2563359-A1 NOVEL TREATMENT FOR AGE RELATED MACULAR DEGENERATION AND OCULAR ISCHEMIC DISEASE ASSOCIATED WITH COMPLEMENT ACTIVATION BY TARGETING 5-LIPOXYGENASE Allergan, Inc. (US) 2013-03-06 EP disclosed
WO-2011137363-A1 NOVEL TREATMENT FOR AGE RELATED MACULAR DEGENERATION AND OCULAR ISCHEMIC DISEASE ASSOCIATED WITH COMPLEMENT ACTIVATION BY TARGETING 5-LIPOXYGENASE ALLERGAN, INC. (US) 2011-11-03 WO disclosed
EP-1015544-B1 METHOD FOR ENHANCING THE ACTIVITY OF AN ENZYME UNILEVER NV (NL) 2001-10-24 EP disclosed
US-6169065-B1 PROMOTING THE ACTIVITY OF OXIDOREDUCTASES IN WASHING PROCESS FOR BLEACHING FABRICS; INHIBITING THE TRANSFER OF A TEXTILE DYE FROM ONE DYED FABRIC ONTO THE SAME OR ANOTHER FABRIC LEVER BROTHERS COMPANY DIVISION OF CONOPCO COMPANY 2001-01-02 US disclosed
EP-1015544-A1 METHOD FOR ENHANCING THE ACTIVITY OF AN ENZYME UNILEVER N.V. (NL) 2000-07-05 EP disclosed
WO-1999013038-A1 METHOD FOR ENHANCING THE ACTIVITY OF AN ENZYME UNILEVER N.V. (NL) 1999-03-18 WO disclosed
US-5026846-A Process for the preparation of diaryl sulphides and diaryl selenides RHONE-POULENC SANTE (FR) 1991-06-25 US disclosed